Chelerythrine and Sanguinarine Dock at Distinct Sites on BclXL that are Not the Classic BH3 Binding Cleft

Journal of Molecular Biology

Volumn 364, Issue 3, 2006, Pages 536-549

  Zhang, Yong Hong ^a   Bhunia, Anirban ^a   Wan, Kah Fei ^b   Lee, Mei Chin ^b   Chan, Shing Leng ^b   Yu, Victor C K ^b   Mok, Yu Keung ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

apoptosis; BclXL; BH groove; chelerythrine; sanguinarine

Indexed keywords

ALKALOID; BENZOPHENANTHRIDINE DERIVATIVE; BH3 PROTEIN; CHELERYTHRINE; HETERODIMER; PROTEIN BCL XL; SANGUINARINE;

ARTICLE; BINDING SITE; DRUG TARGETING; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY;

MAMMALIA; RUMEX;

EID: 33750806817     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.09.023     Document Type: Article

References (49)

1. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39 (2003) 615-647
2. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., et al. Structure of Bcl-XL-Bak peptide complex: recognition between regulators of apoptosis. Science 275 (1997) 983-986
3. L regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J. 18 (1999) 632-643
4. Zou H., Henzel W.J., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405-413
5. Cheng E.H.-Y., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278 (1997) 1966-1968
6. Chang B.S., Minn A.J., Muchmore S.W., Fesik S.W., and Thompson C.B. Identification of a novel regulatory domain in Bcl-XL and Bcl-2. EMBO J. 16 (1997) 968-977
7. Buolamwini J.K. Novel anticancer drug discovery. Curr. Opin. Chem. Biol. 3 (1999) 500-509
8. Chan S.-L., and Yu C.V. Proteins of the Bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin. Expt. Pharm. Physiol. 31 (2004) 119-128
9. Holinger E.P., Chitenden T., and Lutz R.J. Bak BH3 peptides antagonize Bcl-XL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274 (1999) 13298-13304
10. Degterev A., Lugovskoy A., Cardone M., Mulley B., Wagner G., Mitchison T., and Yuan J. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-XL. Nature Cell Biol. 3 (2001) 173-182
11. Tzung S.-P., Kim K.M., Basanez G., Giedt C.D., Simon J., Zimmerberg J., et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature Cell Biol. 3 (2001) 183-191
12. Kitada S., Leone M., Sareth S., Zhai D., Reed J.C., and Pellecchia M. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J. Med. Chem. 46 (2003) 4259-4264
13. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
14. Ahmad N., Gupta S., Husain M.M., Heiskanen K.M., and Mukhtar H. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin. Cancer Res. 6 (2000) 1524-1528
15. Adhami V.M., Aziz M.H., Mukhtar H., and Ahmad N. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortal human HaCaT keratinocytes. Clin. Cancer Res. 9 (2003) 3176-3182
16. Chan S.-L., Lee M.C., Tan K.O., Yang L.-K., Lee A.S.Y., Flotow H., et al. Identification of chelerythrine as an inhibitor of Bcl-XL function. J. Biol. Chem. 278 (2003) 20453-20456
17. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., and Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nature Cell Biol. 6 (2004) 1221-1228
18. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit becline 1-dependent autophagy. Cell 122 (2005) 927-939
19. Shuker S.B., Hajduk P.J., Meadows R.P., and Fesik S.W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274 (1996) 1531-1534
20. Mayer M., and Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123 (2001) 6108-6117
21. Meyer B., and Peters T. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem. Int. Ed. 42 (2003) 864-890
22. Bhunia A., Jayalakshmi V., Benie A.J., Schuster O., Kelm S., Ramakrishna N., and Peters T. Saturation transfer difference NMR and computational modeling of a sialoadhesin-sialyl lactose complex. Carbohydr. Res. 339 (2004) 259-267
23. Jayalakshmi V., and Rama Krishna N. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes. J. Magn. Reson. 155 (2002) 106-118
24. Jayalakshmi V., and Rama Krishna N. CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities. J. Magn. Reson. 168 (2004) 36-45
25. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., et al. X-ray and NMR structure of human Bcl-x sub L, an inhibitor of programmed cell death. Nature 381 (1996) 335-341
26. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 (1998) 1639-1662
27. Abagyan R.A., Totrov M.M., and Kuznetsov D.N. ICM - a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15 (1994) 488-506
28. Lugovskoy A.A., Degterev A.I., Fahmy A.F., Zhou P., Gross J.D., Yuan J., and Wagner G. A novel approach for characterizing protein ligand complexes: molecular basis for specificity of small-molecule Bcl-2 inhibitors. J. Am. Chem. Soc. 124 (2002) 1234-1240
29. Aritomi M., Kunishima N., Inohara N., Ishibashi Y., Ohta S., and Morikawa K. Crystal structure of Rat Bcl-XL. J. Biol. Chem. 272 (1997) 27886-27892
30. Mayer M., and Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38 (1999) 1784-1788
31. Zhai D., Jin C., Satterthwait A.C., and Reed J.C. Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins. Cell Death Differ. 13 (2006) 1419-1421
32. Clem R.J., Cheng E.H.-Y., Karp C.L., Kirsch D.G., Ueno K., Takahashi A., et al. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl Acad. Sci. USA 95 (1998) 554-559
33. Deverman B.E., Cook B.L., Manson S.R., Niederhoff R.A., Langer E.M., Rosova I., et al. Bcl-XL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111 (2002) 51-62
34. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.-H., Cao X., et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116 (2004) 527-540
35. 3R. Nature Cell Biol. 7 (2005) 1021-1028
36. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., and Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402 (1999) 672-676
37. Edinger A.L., and Thompson C.B. Defective autophagy leads to cancer. Cancer Cell 4 (2003) 422-424
38. Kang C.B., Tai J., Chia J., and Yoon H.S. The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38). FBES Letters 579 (2005) 1469-1476
39. Shirane M., and Nakayama K.I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nature Cell Biol. 5 (2003) 1-10
40. Takehara T., and Takahashi H. Suppression of Bcl-XL deamidation in human hepatocellular carcinomas. Cancer Res. 63 (2003) 3054-3057
41. Wittekind M., and Mueller L. HNCACB, a high-sensitivity 3D NMR experiment to correlate amide-proton and nitrogen resonances with the alpha- and beta-carbon resonances in proteins. J. Magn. Reson. ser. B 101 (1993) 201-205
42. 15N-enriched proteins. J. Biomol. NMR 3 (1993) 185-204
43. 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry 28 (1989) 8972-8979
44. 13C magnetization. J. Magn. Reson. ser. B 101 (1993) 114-119
45. 2O samples of proteins. J. Magn. Reson. ser. B 101 (1993) 333-337
46. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
47. Johnson B.A., and Blevins R.A. NMRView: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
48. 3 in native platelets than in liposomes. J. Am. Chem. Soc. 127 (2005) 916-919
49. Chan S.-L., Tan K.-O., Zhang L., Yee K.S.Y., Ronca F., Chan M.Y., and Yu V.C. F1Aα, a death receptor-binding protein homologus to the Caenorhabditis elegans sex-determining protein, FEM-1, is a caspase substrate that mediates apoptosis. J. Biol. Chem. 274 (1999) 32461-32468